Quality of frozen transfusable plasma prepared from whole blood donations in Canada: An update

2013 ◽  
Vol 49 (3) ◽  
pp. 440-446 ◽  
Author(s):  
William P. Sheffield ◽  
Varsha Bhakta ◽  
Kimberley Talbot ◽  
Edward L.G. Pryzdial ◽  
Craig Jenkins
Keyword(s):  
2018 ◽  
Vol 13 (4) ◽  
pp. 440-445
Author(s):  
Lara A.E. de Laleijne-Liefting ◽  
Johan W. Lagerberg ◽  
Dirk de Korte

Transfusion ◽  
2010 ◽  
Vol 50 (5) ◽  
pp. 1043-1049 ◽  
Author(s):  
William P. Sheffield ◽  
Varsha Bhakta ◽  
Craig Jenkins ◽  
Dana V. Devine

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Olli Lainiala ◽  
Mari Karsikas ◽  
Aleksi Reito ◽  
Antti Eskelinen

AbstractDue to the risk of adverse reactions to metal debris resulting from increased wear of the arthroplasty more than one million metal-on-metal (MoM) hip replacements worldwide are in active follow-up. Follow-up usually includes measurement of both whole blood cobalt (Co) and chromium (Cr) concentrations. Our experience is that Cr is seldom independently elevated. We wanted to ascertain whether blood Cr measurements could be omitted from follow-up protocols without lowering the quality of follow-up. We identified 8438 whole blood Co and Cr measurements performed without or prior to revision surgery. When the cut-off levels 5 µg/L and 7 µg/L were used, Cr was independently elevated in only 0.5% (95% confidence interval, CI, 0.3 to 0.6) and 0.2% (CI 0.1 to 0.3) of the measurements. The models with continuous variables showed that the higher the blood metal concentrations are the lower the percentage of measurements with Cr higher than Co. Our results suggest that whole blood Cr is very rarely independently elevated and therefore the authorities should consider omitting Cr measurements from their screening guidelines of MoM hip replacements. We believe this change in practice would simplify follow-up and lead to cost savings without decreasing the quality of follow-up.


Transfusion ◽  
2021 ◽  
Vol 61 (S1) ◽  
Author(s):  
Turid Helen Felli Lunde ◽  
Lindsay Hartson ◽  
Shawn Lawrence Bailey ◽  
Tor Audun Hervig
Keyword(s):  

Transfusion ◽  
2021 ◽  
Author(s):  
Jean Stanley ◽  
Susan L. Stramer ◽  
Yasuko Erickson ◽  
Julie Cruz ◽  
Jed Gorlin ◽  
...  

Vox Sanguinis ◽  
2002 ◽  
Vol 82 (2) ◽  
pp. 55-60 ◽  
Author(s):  
P. Perez ◽  
C. Bruneau ◽  
M. Chassaigne ◽  
L. R. Salmi ◽  
L. Noel ◽  
...  

Vox Sanguinis ◽  
2018 ◽  
Vol 113 (7) ◽  
pp. 622-631 ◽  
Author(s):  
Catherine Ravanat ◽  
Arnaud Dupuis ◽  
Nadine Marpaux ◽  
Christian Naegelen ◽  
Guillaume Mourey ◽  
...  
Keyword(s):  

2018 ◽  
Vol 64 (5) ◽  
pp. 810-819 ◽  
Author(s):  
Xinyu Liu ◽  
Miriam Hoene ◽  
Peiyuan Yin ◽  
Louise Fritsche ◽  
Peter Plomgaard ◽  
...  

Abstract BACKGROUND Nonadherence to standard operating procedures (SOPs) during handling and processing of whole blood is one of the most frequent causes affecting the quality of serum and plasma. Yet, the quality of blood samples is of the utmost importance for reliable, conclusive research findings, valid diagnostics, and appropriate therapeutic decisions. METHODS UHPLC-MS-driven nontargeted metabolomics was applied to identify biomarkers that reflected time to processing of blood samples, and a targeted UHPLC-MS analysis was used to quantify and validate these biomarkers. RESULTS We found that (4E,14Z)-sphingadienine-C18-1-phosphate (S1P-d18:2) was suitable for the reliable assessment of the pronounced changes in the quality of serum and plasma caused by errors in the phase between collection and centrifugation of whole blood samples. We rigorously validated S1P-d18:2, which included the use of practicality tests on >1400 randomly selected serum and plasma samples that were originally collected during single- and multicenter trials and then stored in 11 biobanks in 3 countries. Neither life-threatening disease states nor strenuous metabolic challenges (i.e., high-intensity exercise) affected the concentration of S1P-d18:2. Cutoff values for sample assessment were defined (plasma, ≤0.085 μg/mL; serum, ≤0.154 μg/mL). CONCLUSIONS Unbiased valid monitoring to check for adherence to SOP-dictated time for processing to plasma or serum and/or time to storage of whole blood at 4 °C is now feasible. This novel quality assessment step could enable scientists to uncover common preanalytical errors, allowing for identification of serum and plasma samples that should be excluded from certain investigations. It should also allow control of samples before long-term storage in biobanks.


1998 ◽  
Vol 21 (6_suppl) ◽  
pp. 26-30 ◽  
Author(s):  
R. Bruni ◽  
M. Valbonesi ◽  
R. Frisoni ◽  
G. Lercari ◽  
M.R. Ruzzenenti ◽  
...  

Recently, several new cell separators have become available for high platelet low WBC contamination thrombocytapheresis. In their original configuration, these apparatuses can only collect plasma along with platelets, while no concurrent red cell collection can be carried out. In this study, we present the preliminary results of plasma and/or erythrothrombocytapheresis after the adaptation of the lines of two different cell separators, namely the Fresenius AS 204 and the Baxter Health Care Amicus. In addition, the preliminary results of multicomponent collection using the Dideco Excel will be presented; in the latter a system of plasma recirculation was introduced, to increase the purity and quality of the platelet product. The results of these studies show that erythrothrombocytapheresis can be carried out with all these apparatuses, but only with Dideco-Excel and the Fresenius AS 204 the procedure is totally automated. There are marginal differences in the quality of the RBC product in terms of percent hematocrit, from 65% with the Excel and AS 204 to ∼ 75% with the Amicus and in terms total content of hemoglobin which averages 58 g per RBC concentrate when RBC collection is carried out during the processing of ∼ 420 ml of whole blood. In terms of platelet collection, the differences are presently moderate, as the platelet yield and WBC contamination are not affected by the concurrent RBC collection. The average platelet yield was 3.98-4.1, and 4.01x1011 and the total WBC contamination was 1.2-2.9, and 1.9X105 rerspectively with the Amicus, the AS 204 and the Excel. These represent a new step in the direction of total apheresis for blood and blood component procurement.


Transfusion ◽  
2001 ◽  
Vol 41 (1) ◽  
pp. 74-81 ◽  
Author(s):  
Cecile Bruneau ◽  
Paul Perez ◽  
Maurice Chassaigne ◽  
Pierre Allouch ◽  
Andre Audurier ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document